health

New recommendations are needed in part because people with cancer are living longer thanks to improved treatments, giving tumors more time to spread to other parts of the body.

Researchers found that exposure to the pollution caused mice to experience changes in the normal composition of gut bacteria. This in turn produced a cascade of negative health effects.

UCLA School of Nursing researchers found that people with a certain genetic variation who took donepezil for the condition had a faster cognitive decline than those who took a placebo.

UCLA-led study of DNA patterns in tumor cells suggests that the abundance of aberrant genetic signatures common in more aggressive cancers is not random.

Dr. Ippolytos Kalofonos has woven together his interests in global health, medicine and culture into a career as a medical anthropologist.

Dr. Richard Boxer, a visiting professor of urology at UCLA, argues that giving states money to provide high-deductible plans with health savings accounts could save Medicaid.

New UCLA-led research shows which strains of viruses that are transmitted depend on whether transmission occurs during pregnancy or through breastfeeding.

While boxes of decadent chocolate treats, celebratory champagne and romantic, high-calorie dinners may dance in your mind as a way to celebrate Valentine’s Day, your heart may be pining for something else.

UCLA psychiatrist Dr. Larissa Mooney explains in this Q&A how allowing pharmacies to dispense naloxone leads to a reduction in overdoses.

Researchers at UCLA found the same types of abnormalities in the study’s e-cigarette users that are found in tobacco cigarette users. These abnormalities are associated with increased cardiac risk.

The new protocol opens the door to researchers who want to make muscle, bone and cartilage cells in the lab; the scientists plan to study whether the method could be help treat Duchenne muscular dystrophy.

UCLA biologists are exploring ways to defeat antibiotic-resistant bacteria; a mathematical formula they created can help predict which combinations of drugs will be most effective.

UCLA researchers determined for the first time why some people with advanced melanoma or advanced colon cancer will not respond to pembrolizumab.

For generations, doctors told women who were born with complex congenital heart defects that the physical demands of pregnancy would be too difficult for them.

The study is the first to evaluate the medication as a possible treatment for alcoholism.

The researchers will identify biomarkers associated with the development of epilepsy and develop therapies designed to prevent or modify the condition.

Join Dr. Anne Schuchat, acting director for the Centers for Disease Control for a discussion on the inevitability of health threats and the preventability of global health catastrophes.

Researchers found that combining a vaccine developed at UCLA with two drugs that modulate distinct aspects of the immune system was more effective at allowing T cells to attack glioblastoma than the vaccine alone.

A UCLA-led research team has identified a drug and dose regimen that may cut the time by as much as 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.

New UCLA research finds that mental sharpness in women begins to decline as early as their 50s.

Researchers have demonstrated how specialized proteins are able to change the cellular characteristics of skin cells and create induced pluripotent stem cells, which have the ability to turn into any cell type in the body. The findings could influence the creation of healthy tissues to cure disease.

UCLA Jonsson Comprehensive Cancer Center researchers discuss the parallels — and the sometimes unexpected intersections between the two pursuits.

Blood donors representing many ethnicities and backgrounds pool precious resource to save woman’s life.

The device, developed by UCLA’s Aydogan Ozcan and colleagues in Sweden, could be manufactured for less than $500 each — far less expensive than the equipment that labs use for the same tests.

Dr. Edward Garon, UCLA Jonsson Comprehensive Cancer Center member and associate professor of hematology and oncology at the David Geffen School of Medicine, has received a new grant from the National Institutes of Health.